Elemind is a Non-Invasive Consumer EEG company founded in 2020 and based in Cambridge, United States. It has raised $12M in total funding, most recently a Seed in 2024.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Feb 6, 2024 | Seed | $12M | — | Village Global, LDV Partners |
No articles ingested yet for Elemind. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
Consumer EEG wearable that uses real-time brainwave monitoring and phase-locked acoustic stimulation to accelerate sleep onset. Sensors detect the user's ongoing EEG rhythms and the device emits precisely-timed audio pulses through built-in speakers to entrain slow-wave activity, reducing time-to-sleep without drugs. Based on peer-reviewed MIT neuroscience research on gamma and delta entrainment. Commercially launched in 2024; targeted at adults with difficulty falling asleep.